Industry Expert and Analysis
February 3, 2026
Pune, India | December 15, 2025 The U.S. FDA has approved niraparib combined with abiraterone acetate and prednisone for adults with BRCA2 prostate cancer, specifically
Read MorePune, India | October 27, 2025 The U.S. Food and Drug Administration (FDA) recently approved revumenib, an innovative oral menin inhibitor, to treat relapsed or
Read MorePune, India | October 07, 2025 The U.S. Food and Drug Administration (FDA) has officially approved a new maintenance therapy for adults with extensive-stage small
Read MorePune, India | October 03, 2025 The U.S. Food and Drug Administration (FDA) has approved Evkeeza® (evinacumab‑dgnb) for children as young as one year diagnosed
Read More